Skip to Content
Merck

Skip To

A1812

Monoclonal Anti-FITC−Alkaline Phosphatase antibody produced in mouse

clone FL-D6, purified immunoglobulin, buffered aqueous solution

Synonym(s):

Monoclonal Anti-FITC

Sign In to View Organizational & Contract Pricing.

About This Item

NACRES:
NA.46
UNSPSC Code:
12352203
Conjugate:
alkaline phosphatase conjugate
Clone:
FL-D6, monoclonal
Application:
DB, ELISA (i), IHC (p)
Citations:
4


biological source

mouse

Quality Level

recombinant

expressed in mouse cell line

conjugate

alkaline phosphatase conjugate

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

FL-D6, monoclonal

form

buffered aqueous solution

technique(s)

dot blot: 1:80,000 using human IgG/FITC monoclonal anti-human IgG, immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:20 using FITC conjugate, indirect ELISA: 1:30,000

isotype

IgG1

shipped in

wet ice

storage temp.

2-8°C

target post-translational modification

unmodified

General description

FITC (fluorescein isothiocyanate) is a fluorochrome dye that absorbs ultraviolet or blue light causing molecules to become excited and emit a visible yellow-green light. This emission ceases upon removal of the light causing the excitation. Fluorochrome labeling provides rapid, accurate localization of antigen-antibody interaction when one of the reactants is part of a cell, tissue or other biological structure. FITC is a commonly used marker for antibodies in immunofluorescent techniques because the conjugation of FITC to proteins is relatively easy and generally does not destroy the biological activity of the labeled protein. FITC is widely used as a hapten to label different proteins. Antibodies to FITC are used to identify FITC labeled proteins and as models to study the mechanism of antibody response to a well defined hapten. Monoclonal Anti-FITC (mouse IgG1 isotype) is derived from the hybridoma produced by the fusion of mouse myeloma cells and splenocytes from an immunized mouse.

Immunogen

FITC-BSA conjugate

Application

Alkaline phosphatase-conjugated mouse anti-FITC antibody was used for immunohistochemistry[1] on mouse spleens. Tissue sections were fixed in acetone, blocked with PBS/5% goat serum/ 0.1% Tween and incubated with a FITC-conjugated primary antibody prior to the addition of the AP-conjugated anti-FITC antibody.
Antibodies to FITC serve as universal indicator reagents by bridging FITC with another immunohistochemical reagent such as alkaline phosphatase or horseradish peroxidase. Mouse monoclonal clone FL-D6 anti-FITC−Alkaline Phosphatase conjugate antibody may be used for the detection of FITC and as a universal indicator reagent for bridging FITC with other immunochemical reagents. It can be used in ELISA and immunofluorescent techniques.
Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunohistochemistry (1 paper)

Biochem/physiol Actions

The antibody reacts with both free and conjugated fluorescein isothiocyanate (FITC).

Physical form

Solution in 0.05 M Tris buffer, pH 8.0, containing 1% bovine serum albumin, 50% glycerol, 1 mM MgCl2 and 15 mM sodium azide

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
F5636SAB4200738B0287
antibody form

purified immunoglobulin

antibody form

ascites fluid

antibody form

purified from hybridoma cell culture

antibody form

purified immunoglobulin

clone

FL-D6, monoclonal

clone

FL-D6, monoclonal

clone

FL-D6, monoclonal

clone

FL-D6, monoclonal

conjugate

alkaline phosphatase conjugate

conjugate

unconjugated

conjugate

-

conjugate

biotin conjugate

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

technique(s)

dot blot: 1:80,000 using human IgG/FITC monoclonal anti-human IgG, indirect ELISA: 1:30,000, immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:20 using FITC conjugate

technique(s)

indirect ELISA: 1:2,500 using FITC-conjugate, indirect immunofluorescence: suitable

technique(s)

immunoblotting: 1.25-2.5 μg/mL using ExtrAvidin-FITC, immunohistochemistry: suitable, indirect ELISA: 0.15-0.3 μg/mL using 5 μg/ml ExtrAvidin-FITC

technique(s)

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:400 using human tonsil

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200


Still not finding the right product?

Try our Product Selector Tool to narrow your options


Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content


Martyn A Sharpe et al.
EBioMedicine, 2(9), 1122-1132 (2015-10-27)
The last major advance in the treatment of glioblastoma multiforme (GBM) was the introduction of temozolomide in 1999. Treatment with temozolomide following surgical debulking extends survival rate compared to radiotherapy and debulking alone. However, virtually all glioblastoma patients experience disease
Helder I Nakaya et al.
Proceedings of the National Academy of Sciences of the United States of America, 113(7), 1853-1858 (2016-01-13)
The dynamics and molecular mechanisms underlying vaccine immunity in early childhood remain poorly understood. Here we applied systems approaches to investigate the innate and adaptive responses to trivalent inactivated influenza vaccine (TIV) and MF59-adjuvanted TIV (ATIV) in 90 14- to
H Noorchashm et al.
Journal of immunology (Baltimore, Md. : 1950), 163(2), 743-750 (1999-07-08)
B cell-deficient nonobese diabetic (NOD) mice are protected from the development of spontaneous autoimmune diabetes, suggesting a requisite role for Ag presentation by B lymphocytes for the activation of a diabetogenic T cell repertoire. This study specifically examines the importance



Global Trade Item Number

SKUGTIN
A1812-.5ML04061836275365
A1812-.2ML04061837854781

Questions

Reviews

No rating value

Active Filters